FDA Clears Self-Administered Lupus Therapy - Quiz - MDSpire

FDA Clears Self-Administered Lupus Therapy

Once-weekly autoinjector approval was based on Phase 3 data, with safety consistent with intravenous administration.

  • By

  • Kathryn Wighton

  • April 28, 2026

  • 2 min

Share

Original Source(s)

FDA Clears Self-Administered Lupus Therapy

  • by Kathryn Wighton

  • April 28, 2026

Related Content

Genistein in autoimmune diseases: from experimental evidence to emerging clinical data

Systemic lupus erythematosus–driven accelerated atherosclerosis: the immune–metabolic–vascular axis and therapeutic implications

Global research landscape and emerging trends of tertiary lymphoid structures in autoimmune diseases: a bibliometric analysis